BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3609877)

  • 21. Evaluation and registration of adverse events in clinical drug trials in migraine.
    Tfelt-Hansen P; Bjarnason NH; Dahlöf C; Derry S; Loder E; Massiou H;
    Cephalalgia; 2008 Jul; 28(7):683-8. PubMed ID: 18498392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine prophylaxis: key points for the practising clinician.
    Moschiano F; D'Amico D; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S33-7. PubMed ID: 19415423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.
    Silberstein S; Tfelt-Hansen P; Dodick DW; Limmroth V; Lipton RB; Pascual J; Wang SJ;
    Cephalalgia; 2008 May; 28(5):484-95. PubMed ID: 18294250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An extract of Petasites hybridus is effective in the prophylaxis of migraine.
    Grossman W; Schmidramsl H
    Altern Med Rev; 2001 Jun; 6(3):303-10. PubMed ID: 11410074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin as preventive treatment for migraine: a randomized double-blind study.
    Petri S; Tölle T; Straube A; Pfaffenrath V; Stefenelli U; Ceballos-Baumann A;
    Eur Neurol; 2009; 62(4):204-11. PubMed ID: 19622887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study.
    Vécsei L; Gallacchi G; Sági I; Semjén J; Tajti J; Szok D; Müller M; Vadass P; Kerékgyártó M
    Cephalalgia; 2007 Jan; 27(1):29-34. PubMed ID: 17212680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transparently blinded trials of methysergide.
    Gaudet RJ; Kessler II
    N Engl J Med; 1987 Jan; 316(5):279-80. PubMed ID: 3540672
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine.
    Cephalalgia; 1991 Feb; 11(1):1-12. PubMed ID: 2036663
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
    Pradalier A; Dry J; Loisy B; Meininger V; Vicaut E; Mirabaud C; Levy M
    Therapie; 1988; 43(4):293-7. PubMed ID: 3055407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of cephalalgia in migraine].
    Ortiz P
    Rev Neuropsiquiatr; 1978; 41(3-4):101-12. PubMed ID: 398068
    [No Abstract]   [Full Text] [Related]  

  • 33. Polytherapy for migraine prophylaxis.
    Casucci G; Villani V; Cologno D; D'Onofrio F
    Neurol Sci; 2012 May; 33 Suppl 1():S147-50. PubMed ID: 22644191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A further step in migraine prevention].
    Fortschr Med Suppl; 1985; 8():11-3. PubMed ID: 2867018
    [No Abstract]   [Full Text] [Related]  

  • 35. Using the maximum test statistic in the two-period crossover clinical trial.
    Willan AR
    Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials in migraine: parallel versus crossover studies.
    Kunkel RS
    Neuroepidemiology; 1987; 6(4):209-13. PubMed ID: 3683715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine blood-pressure lowering effect in migraine patients. A clinical investigation for a possible mechanism.
    Steardo L; Marano E; Sorge F
    Acta Neurol (Napoli); 1979 Oct; 1(5):379-86. PubMed ID: 390977
    [No Abstract]   [Full Text] [Related]  

  • 38. Migraine trials: crossover or parallel group?
    Lewis JA
    Neuroepidemiology; 1987; 6(4):198-208. PubMed ID: 3683714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxprenolol in the treatment of migraine.
    Ekbom K; Zetterman M
    Acta Neurol Scand; 1977 Aug; 56(2):181-4. PubMed ID: 331835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled clinical trials of drugs for use in the prophylaxis of migraine.
    Hübbe P
    Dan Med Bull; 1975 Mar; 22(3):92-6. PubMed ID: 1093819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.